Roniciclib

DB12974InvestigationalSmall molecule

Roniciclib has been investigated for the treatment of Small Cell Lung Carcinoma.

Chemical structure of Roniciclib
Mechanism
Curator reviewed
Formula / weight
C18H21F3N4O3S · 430.45 g/mol (avg)
Code names
BAY10-00394

Resolves to

Compound
UNII0W9Q8U337ACAS1223498-69-8PubChem71494949
Structure
InChIKeyUELYDGOOJPRWGF-SRQXXRKNSA-NSMILESC[C@@H](O)[C@@H](C)OC1=C(C=NC(NC2=CC=C(C=C2)[S@](=N)(=O)C2CC2)=N1)C(F)(F)F
Targets
P24941CDK2P50750CDK9P11802CDK4P06493CDK1

What you can answer from here — as of June 15, 2026

5Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
6+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Roniciclib, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In